Sentinel Oncology Limited is a biotechnology company based in Cambridge, UK, focused on developing innovative therapies for cancer treatment. The organization specializes in harnessing advanced technologies to create targeted therapies that aim to improve patient outcomes. With a commitment to research and development, Sentinel Oncology is dedicated to addressing unmet medical needs in oncology, leveraging its expertise to advance the field of cancer therapeutics and enhance the quality of life for patients.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#85 in Cambridge

#1,458 in United Kingdom

#48,163 in the World

Cambridge, United Kingdom

Sentinel Oncology Limited

Forward Citations = 18

8 inventors:

Robert George Boyle (12 out of 24 patents)

David Winter Walker (11 out of 18 patents)

Richard Justin Boyce (6 out of 7 patents)

4. Scott Peterson (2 out of 5 patents)

5. Francine Farouz (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sentinel Oncology Limited. Retrieved from https://idiyas.com/company/sentinel-oncology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

9 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]